Revolutionary gene-editing therapy for sickle cell ‘offers hope of a cure’ for NHS patients

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as exagamglogene autotemcel (or ‘exa-cel’), has been approved for use on the NHS in England from today (Friday 31 January) by the National Institute […]

Read More  on the NHS website.